Skip to content
HowShorted

Tonix Pharmaceuticals Holding short interest in 2018

In 2018, Tonix Pharmaceuticals Holding's disclosed short interest ran from 3.38% of shares outstanding on 12 Jan 2018 to 9.64% on 15 Nov 2018, a change of +6.26 percentage points. The year's high was 14.92% on 31 Oct 2018 and its low 2.03% on 13 Jul 2018, averaging 4.66% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 10.84 days on 28 Feb 2018. Full history: Tonix Pharmaceuticals Holding.

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2025 · 2026

Aggregate net short position time series for Tonix Pharmaceuticals Holding in 2018

2018 in figures

Start of year
3.38% (12 Jan 2018)
End of year
9.64% (15 Nov 2018)
Change
+6.26 pp
High
14.92% (31 Oct 2018)
Low
2.03% (13 Jul 2018)
Average
4.66%
Highest days to cover
10.84 (28 Feb 2018)
SEC filings marked
8

Every report in 2018

Tonix Pharmaceuticals Holding short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20183.38%4.94
31 Jan 20183.41%2.38
15 Feb 20183.56%5.20
28 Feb 20183.35%10.84
15 Mar 20182.81%5.1610-K filed, results (8-K)
29 Mar 20182.93%3.87
13 Apr 20182.82%2.89
30 Apr 20182.51%3.52
15 May 20182.90%1.9810-Q filed, results (8-K)
31 May 20182.52%3.27
15 Jun 20182.72%1.00
29 Jun 20182.83%1.17
13 Jul 20182.03%1.05
15 Aug 20182.17%1.0010-Q filed, results (8-K)
31 Aug 20185.41%1.00
14 Sep 20184.96%1.44
28 Sep 20186.11%2.13
15 Oct 201812.29%1.00
31 Oct 201814.92%1.00
15 Nov 20189.64%1.2110-Q filed, results (8-K)

See also: Tonix Pharmaceuticals Holding's full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.